NOTE: If you are having login problems due to recent site updates, please try either clearing your browser cache, quitting and restarting your browser, or restarting/rebooting your computer/device and try again. Please email tech support if you have continued problems.


GRACE :: Breast Cancer

Dr. Hy Muss on Breast Cancer in Older Women: Advanced/Metastatic Cancer and Importance of Functional Status

Dr. Muss closes his presentation with a discussion of the importance of assessing functional status of older patients with breast cancer, as well as other cancers, in making recommendations for the optimal treatment approach.  Here he describes the potential value of more aggressive treatments, along with the need to be judicious in our recommendations in order to reduce the risk of patients developing prohibitive side effects from the therapy.

Below you’ll find the video and audio versions of the podcast along with the transcript and figures for this program.

Muss BC in Older Women Pt 4 Advanced BC and Functional Assessment Audio Podcast

Muss BC in Older Women Pt 4 Advanced BC and Functional Assessment Transcript

Muss BC in Older Women Pt 4 Advanced BC and Functional Assessment Figs

Continue reading


Breast Cancer in Older Women: Surgery and Adjuvant Therapy, by Dr. Hy Muss

Dr. Hy Muss, breast cancer expert with a special expertise in treatment of older patients with cancer, continues his presentation on breast cancer in older women with a discussion of the evolution of surgery recommendations in breast cancer, along with a wonderful discussion of how he approaches the benefit vs. risk discussion for post-operative (adjuvant) therapy.  I found myself thinking that his explanation was so helpful that I’d want to incorporate elements of his presentation into my own discussions of the complex issues around adjuvant therapy.

Here are the video and audio versions of the program, along with the associated transcript and figures.

Muss BC in Older Women Pt 3 Surgery and Adjuvant Rx Audio Podcast

Muss BC in Older Women Pt 3 Surgery and Adjuvant Rx Transcript

Muss BC in Older Women Pt 3 Surgery and Adjuvant Rx Figures

Continue reading


Dr. Hy Muss on Breast Cancer Prevention, Screening, and Goals of Therapy in Older Women

Here’s the second podcast from Dr. Hy Muss’s great presentation on breast cancer in older women. In this portion, he discusses considerations in prevention, the controversial role of breast cancer screening as women get older and may not benefit from further screening, and also defining the goals of therapy once breast cancer is diagnosed.

Here are the video and audio versions of the podcast, along with the associated transcript and figures.

Muss Breast Ca in Older Women Pt 2 Prevention, Screening, Goals of Rx Audio Podcast

Muss Breast Ca in Older Women Pt 2 Prevention, Screening, Goals of Rx Transcript

Muss Breast Ca in Older Women Pt 2 Prevention, Screening, Goals of Rx Figures

Continue reading


Dr. Hy Muss on Breast Cancer in Older Women: Population Trends by Age

Dr. Hy Muss, medical oncologist and Director of the Geriatric Oncology Program at the University of North Carolina, Chapel Hill, is both a renowned expert in breast cancer and among the world’s leading luminaries on the important topic of cancer care in older patients.  Though many times it’s young celebrities with breast or other cancer who gather the attention of the media, in truth cancer is a disease that still disproportionately affects older people.  Much of the cancer in the real world of our oncology clinics is elderly patients, who are also understudied in our research relative to their importance as a population.

Dr. Muss was kind enough to sit down with our own very excellent Dr. Jared Weiss, also at UNC-Chapel Hill, to do a slide-based presentation of the leading important points on breast cancer in older women. Here’s the first part of that presentation, including video and audio versions of the podcast, along with the associated transcript and figures.

Muss Breast Ca in Older Women Pt 1 Pop Trends by Age Audio Podcast

Muss Breast Ca in Older Women Pt 1 Pop Trends by Age Transcript

Muss Breast Ca in Older Women Pt 1 Pop Trends by Age Figures

Continue reading


Is One Year of Adjuvant Herceptin for Early Stage Breast Cancer Really Optimal?

Since the FDA approval of Herceptin in the adjuvant setting for HER2-positive, early stage breast cancer, one year of Herceptin has been the standard length of therapy. This was based on the design of multiple, large, randomized trials that were published in 2005. Many people, however, argued that the choice of one year was not based on scientific data, and that is was somewhat arbitrary. Two studies presented at the 2012 Congress of the European Society for Medical Oncology (ESMO) in Vienna this past week, however, supported the belief that one year of therapy is optimal. In the two studies presented at ESMO, investigators evaluated both shorter and longer durations of Herceptin treatment.

Continue reading


Ask Us, Q&A
Breast Cancer Expert Content

Archives

Lung Cancer Awareness Month Information

 


GRACE Website Rebuild

Join the GRACE Faculty

Lung/Thoracic Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog

Subscribe to the GRACEcast Podcast on iTunes

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
   (Free Newsletter)

Other Resources

ClinicalTrials.gov


Biomedical Learning Institute

PeerView Press - Curriculum-Based Learning Activities